On 3 February 2015
Jubilant Life Sciences will hold a meeting of the Board of Directors of the Company on 3 February 2015, to consider and approve the Unaudited Financial Results of the Company for the quarter ended 31 December 2014 (Q3).Powered by Capital Market - Live News
